175 related articles for article (PubMed ID: 34893510)
61. Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling.
Zhang G; Miao F; Liu K; Wu J; Xu J
Technol Cancer Res Treat; 2021; 20():15330338211034270. PubMed ID: 34269120
[TBL] [Abstract][Full Text] [Related]
62. Role of triptolide in cell proliferation, cell cycle arrest, apoptosis and histone methylation in multiple myeloma U266 cells.
Zhao F; Chen Y; Zeng L; Li R; Zeng R; Wen L; Liu Y; Zhang C
Eur J Pharmacol; 2010 Nov; 646(1-3):1-11. PubMed ID: 20547150
[TBL] [Abstract][Full Text] [Related]
63. HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
Caslini C; Hong S; Ban YJ; Chen XS; Ince TA
Oncogene; 2019 Sep; 38(39):6599-6614. PubMed ID: 31375747
[TBL] [Abstract][Full Text] [Related]
64. EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.
Yan J; Ng SB; Tay JL; Lin B; Koh TL; Tan J; Selvarajan V; Liu SC; Bi C; Wang S; Choo SN; Shimizu N; Huang G; Yu Q; Chng WJ
Blood; 2013 May; 121(22):4512-20. PubMed ID: 23529930
[TBL] [Abstract][Full Text] [Related]
65. The mechanism of SP1/p300 complex promotes proliferation of multiple myeloma cells through regulating IQGAP1 transcription.
Jin Z; Zhou S; Ye H; Jiang S; Yu K; Ma Y
Biomed Pharmacother; 2019 Nov; 119():109434. PubMed ID: 31536933
[TBL] [Abstract][Full Text] [Related]
66. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
Hu Z; Huang G; Sadanandam A; Gu S; Lenburg ME; Pai M; Bayani N; Blakely EA; Gray JW; Mao JH
Breast Cancer Res; 2010; 12(2):R18. PubMed ID: 20211017
[TBL] [Abstract][Full Text] [Related]
67. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
[TBL] [Abstract][Full Text] [Related]
68. HJURP regulates cell proliferation and chemo-resistance via YAP1/NDRG1 transcriptional axis in triple-negative breast cancer.
Mao M; Jia Y; Chen Y; Yang J; Xu L; Zhang X; Zhou J; Li Z; Chen C; Ju S; Wang L
Cell Death Dis; 2022 Apr; 13(4):396. PubMed ID: 35459269
[TBL] [Abstract][Full Text] [Related]
69. DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.
Alberge JB; Magrangeas F; Wagner M; Denié S; Guérin-Charbonnel C; Campion L; Attal M; Avet-Loiseau H; Carell T; Moreau P; Minvielle S; Sérandour AA
Clin Epigenetics; 2020 Nov; 12(1):163. PubMed ID: 33138842
[TBL] [Abstract][Full Text] [Related]
70. Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia.
Fang F; Lu J; Sang X; Tao YF; Wang JW; Zhang ZM; Zhang YP; Li XL; Xie Y; Wu SY; Chu XR; Li G; Wu D; Chen YL; Yu JJ; Jia SQ; Feng CX; Tian YY; Li ZH; Ling J; Hu SY; Pan J
J Exp Clin Cancer Res; 2022 Jul; 41(1):225. PubMed ID: 35842703
[TBL] [Abstract][Full Text] [Related]
71. Hypomethylation-driven overexpression of HJURP promotes progression of hepatocellular carcinoma and is associated with poor prognosis.
Li Y; Yi Q; Liao X; Han C; Zheng L; Li H; Yu Q; Yan X; Chen X; Zhu H; Zhao B; Lin Q; Liang L; Wang L; Qin F; Xie W; Li Y; Huang W
Biochem Biophys Res Commun; 2021 Aug; 566():67-74. PubMed ID: 34119827
[TBL] [Abstract][Full Text] [Related]
72. Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.
Yang P; Guo L; Duan ZJ; Tepper CG; Xue L; Chen X; Kung HJ; Gao AC; Zou JX; Chen HW
Mol Cell Biol; 2012 Aug; 32(15):3121-31. PubMed ID: 22645312
[TBL] [Abstract][Full Text] [Related]
73. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3.
Lin L; Cao L; Liu Y; Wang K; Zhang X; Qin X; Zhao D; Hao J; Chang Y; Huang X; Liu B; Zhang J; Lu J; Ge Q
Leukemia; 2019 Jun; 33(6):1475-1486. PubMed ID: 30573782
[TBL] [Abstract][Full Text] [Related]
74. EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast Differentiation.
Adamik J; Jin S; Sun Q; Zhang P; Weiss KR; Anderson JL; Silbermann R; Roodman GD; Galson DL
Mol Cancer Res; 2017 Apr; 15(4):405-417. PubMed ID: 28119431
[TBL] [Abstract][Full Text] [Related]
75. Advances in holliday junction recognition protein (HJURP): Structure, molecular functions, and roles in cancer.
Li L; Yuan Q; Chu YM; Jiang HY; Zhao JH; Su Q; Huo DQ; Zhang XF
Front Cell Dev Biol; 2023; 11():1106638. PubMed ID: 37025176
[TBL] [Abstract][Full Text] [Related]
76. The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.
Montes de Oca R; Gurard-Levin ZA; Berger F; Rehman H; Martel E; Corpet A; de Koning L; Vassias I; Wilson LO; Meseure D; Reyal F; Savignoni A; Asselain B; Sastre-Garau X; Almouzni G
Mol Oncol; 2015 Mar; 9(3):657-74. PubMed ID: 25497280
[TBL] [Abstract][Full Text] [Related]
77. Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma.
Xu Y; Guo J; Liu J; Xie Y; Li X; Jiang H; Wang J; Peng Z; Wang J; Wang S; Wan C; Chen L; Zhong Y; Liu B; Liu Z
Oncogene; 2021 Feb; 40(7):1231-1241. PubMed ID: 33420361
[TBL] [Abstract][Full Text] [Related]
78. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
[TBL] [Abstract][Full Text] [Related]
79. Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.
Hudlebusch HR; Theilgaard-Mönch K; Lodahl M; Johnsen HE; Rasmussen T
Br J Haematol; 2005 Sep; 130(5):700-8. PubMed ID: 16115125
[TBL] [Abstract][Full Text] [Related]
80. Holliday Cross-Recognition Protein
Luo D; Liao S; Liu Y; Lin Y; Li Y; Liao X
Pathol Oncol Res; 2022; 28():1610506. PubMed ID: 35783358
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
